A patient-matched, post-relapse serous ovarian cancer model with restored BRCA2 function, used to study HR restoration, platinum resistance and PARP inhibitor resistance. Exclusive to CancerTools.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.